1. Home
  2. PYXS
  3. PYXS News

Latest Pyxis Oncology Inc. (PYXS) News on October 17, 2025

Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics
PYXS

Zacks

2 days ago

Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics

Pyxis Oncology (PYXS) Upgraded to Strong Buy: Here's What You Should Know
PYXS

Zacks

3 days ago

Pyxis Oncology (PYXS) Upgraded to Strong Buy: Here's What You Should Know

5 Small Drug Stocks to Buy as the Industry Shows Some Recovery
PYXS

Zacks

3 days ago

5 Small Drug Stocks to Buy as the Industry Shows Some Recovery

Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings
PYXS

GlobeNewswire

4 days ago

Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings

Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets
PYXS

GlobeNewswire

8 days ago

Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets

September 2025's Promising Penny Stock Opportunities
PYXS

Simply Wall St.

a month ago

September 2025's Promising Penny Stock Opportunities

Pyxis Oncology Insiders Lose Out As Stock Sinks To US$1.14
PYXS

Simply Wall St.

4 months ago

Pyxis Oncology Insiders Lose Out As Stock Sinks To US$1.14

Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update
PYXS

GlobeNewswire

5 months ago

Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update

Pyxis Oncology to Participate in Two Upcoming Investor Conferences
PYXS

GlobeNewswire

5 months ago

Pyxis Oncology to Participate in Two Upcoming Investor Conferences

Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
PYXS

GlobeNewswire

6 months ago

Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC

Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
PYXS

GlobeNewswire

6 months ago

Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025
PYXS

GlobeNewswire

7 months ago

Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025

Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
PYXS

GlobeNewswire

7 months ago

Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Pyxis Oncology to Participate at the Leerink Partners Global Healthcare Conference
PYXS

GlobeNewswire

7 months ago

Pyxis Oncology to Participate at the Leerink Partners Global Healthcare Conference

Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer
PYXS

GlobeNewswire

8 months ago

Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer

Will Pyxis Oncology (NASDAQ:PYXS) Spend Its Cash Wisely?
PYXS

Simply Wall St.

8 months ago

Will Pyxis Oncology (NASDAQ:PYXS) Spend Its Cash Wisely?

Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial
PYXS

GlobeNewswire

8 months ago

Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial

Pyxis Oncology price target lowered to $8 from $10 at RBC Capital
PYXS

TipRanks

10 months ago

Pyxis Oncology price target lowered to $8 from $10 at RBC Capital

Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201
PYXS

GlobeNewswire

10 months ago

Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201

CFO & COO of Pyxis Oncology Pamela Connealy Buys 13% More Shares
PYXS

Simply Wall St.

a year ago

CFO & COO of Pyxis Oncology Pamela Connealy Buys 13% More Shares

Institutional owners may ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) recent US$142m market cap decline as longer-term profits stay in the green
PYXS

Simply Wall St.

a year ago

Institutional owners may ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) recent US$142m market cap decline as longer-term profits stay in the green

Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
PYXS

GlobeNewswire

a year ago

Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024
PYXS

GlobeNewswire

a year ago

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024

Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201
PYXS

GlobeNewswire

a year ago

Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201

Pyxis Oncology to Participate in Two Upcoming Investor Conferences
PYXS

GlobeNewswire

a year ago

Pyxis Oncology to Participate in Two Upcoming Investor Conferences

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024
PYXS

GlobeNewswire

a year ago

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024

Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference
PYXS

GlobeNewswire

a year ago

Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PYXS

GlobeNewswire

a year ago

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Institutional owners may ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) recent US$25m market cap decline as longer-term profits stay in the green
PYXS

Simply Wall St.

a year ago

Institutional owners may ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) recent US$25m market cap decline as longer-term profits stay in the green

FDA panel votes to recommend Eli Lilly's Alzheimer's drug
PYXS

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

PYXS

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit
PYXS

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

PYXS

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
PYXS

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
PYXS

GlobeNewswire

a year ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research
PYXS

GlobeNewswire

a year ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas
PYXS

Business Wire

a year ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
PYXS

GlobeNewswire

a year ago

Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition
PYXS

Business Wire

a year ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus
PYXS

GlobeNewswire

a year ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23
PYXS

GlobeNewswire

a year ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?
PYXS

Simply Wall St.

a year ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May
PYXS

Reuters

a year ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'
PYXS

AFP

a year ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed
PYXS

PR Newswire

a year ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share
PYXS

GlobeNewswire

a year ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses
PYXS

Investor's Business Daily

a year ago

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library
PYXS

Business Wire

a year ago

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap
PYXS

Investor's Business Daily

a year ago

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

EnviroGold Global Closes First Tranche of Private Placement
PYXS

GlobeNewswire

a year ago

EnviroGold Global Closes First Tranche of Private Placement

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)
PYXS

GuruFocus.com

a year ago

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

How markets digested hot jobs print: Top takeaways
PYXS

Yahoo Finance Video

a year ago

How markets digested hot jobs print: Top takeaways

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
PYXS

GlobeNewswire

a year ago

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"
PYXS

PR Newswire

a year ago

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
PYXS

GlobeNewswire

a year ago

Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference

Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
PYXS

GlobeNewswire

a year ago

Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024

Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
PYXS

GlobeNewswire

a year ago

Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PYXS

GlobeNewswire

2 years ago

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
PYXS

GlobeNewswire

2 years ago

Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights

PYXS

GuruFocus.com

2 years ago

Pyxis Oncology Inc (PYXS) Reports Encouraging Clinical Progress Amid Financial Challenges

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
PYXS

GlobeNewswire

2 years ago

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023

Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
PYXS

GlobeNewswire

2 years ago

Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA

Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
PYXS

GlobeNewswire

2 years ago

Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024

Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
PYXS

GlobeNewswire

2 years ago

Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting

Pyxis Oncology Announces $50 Million Private Placement
PYXS

GlobeNewswire

2 years ago

Pyxis Oncology Announces $50 Million Private Placement

PYXS

Business Wire

2 years ago

MFS Releases Closed-End Fund Income Distribution Sources for Certain Funds

Esperion Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
PYXS

GlobeNewswire

2 years ago

Esperion Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock
PYXS

GlobeNewswire

2 years ago

Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock

Dakota Gold Intersects Multiple High-Grade Zones with Visible Gold Mineralization, Including 4.871 oz/ton Au over 3.4 ft (167.0 g/t over 1.0 m), 1200 feet South of the JB Gold Zone on Its Maitland Gold Project
PYXS

Newsfile

2 years ago

Dakota Gold Intersects Multiple High-Grade Zones with Visible Gold Mineralization, Including 4.871 oz/ton Au over 3.4 ft (167.0 g/t over 1.0 m), 1200 feet South of the JB Gold Zone on Its Maitland Gold Project

Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
PYXS

PR Newswire

2 years ago

Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer

Compugen Regains Compliance with Nasdaq Minimum Bid Price Requirement
PYXS

PR Newswire

2 years ago

Compugen Regains Compliance with Nasdaq Minimum Bid Price Requirement

Is KNOT Offshore Partners (KNOP) Stock Undervalued Right Now?
PYXS

Zacks

2 years ago

Is KNOT Offshore Partners (KNOP) Stock Undervalued Right Now?

PYXS

Business Wire

2 years ago

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

PYXS

Business Wire

2 years ago

MFS Announces Closed-End Fund Distributions

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PYXS

GlobeNewswire

2 years ago

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108
PYXS

GlobeNewswire

2 years ago

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108

Biotech Stock Roundup: CGEN Up on GILD Deal, MRNA Gains on Study Data & More
PYXS

Zacks

2 years ago

Biotech Stock Roundup: CGEN Up on GILD Deal, MRNA Gains on Study Data & More

Luna Acquires Silixa
PYXS

Business Wire

2 years ago

Luna Acquires Silixa

PYXS

Business Wire

2 years ago

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

Gilead (GILD), Compugen Collaborate for Immunotherapy Program
PYXS

Zacks

2 years ago

Gilead (GILD), Compugen Collaborate for Immunotherapy Program

Verastem Oncology Selects Oral KRAS G12D Inhibitor GFH375/VS-7375 as Lead Program in Discovery and Development Collaboration with GenFleet Therapeutics
PYXS

Business Wire

2 years ago

Verastem Oncology Selects Oral KRAS G12D Inhibitor GFH375/VS-7375 as Lead Program in Discovery and Development Collaboration with GenFleet Therapeutics

3 Off-the-Beaten-Path Stocks Poised for Substantial Growth
PYXS

InvestorPlace

2 years ago

3 Off-the-Beaten-Path Stocks Poised for Substantial Growth

Verastem Oncology Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer
PYXS

Business Wire

2 years ago

Verastem Oncology Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

Here's Why Sera Prognostics, Inc. (SERA) is a Great Momentum Stock to Buy
PYXS

Zacks

2 years ago

Here's Why Sera Prognostics, Inc. (SERA) is a Great Momentum Stock to Buy

Sight Sciences Announces the Acceptance for Publication of GEMINI 2, a Three Year, Prospective, Multicenter Trial Demonstrating Sustained, Significant IOP and Medication Reductions Enabled with the OMNI® Surgical System Technology
PYXS

GlobeNewswire

2 years ago

Sight Sciences Announces the Acceptance for Publication of GEMINI 2, a Three Year, Prospective, Multicenter Trial Demonstrating Sustained, Significant IOP and Medication Reductions Enabled with the OMNI® Surgical System Technology

While institutions invested in Sera Prognostics, Inc. (NASDAQ:SERA) benefited from last week's 183% gain, retail investors stood to gain the most
PYXS

Simply Wall St.

2 years ago

While institutions invested in Sera Prognostics, Inc. (NASDAQ:SERA) benefited from last week's 183% gain, retail investors stood to gain the most

SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK - ENROLLMENT TO STOP DUE TO SUCCESS
PYXS

PR Newswire

2 years ago

SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK - ENROLLMENT TO STOP DUE TO SUCCESS

Small Stakes, Big Rewards: 3 Penny Stocks with 300% Upside Potential
PYXS

InvestorPlace

2 years ago

Small Stakes, Big Rewards: 3 Penny Stocks with 300% Upside Potential

After Plunging -12.8% in 4 Weeks, Here's Why the Trend Might Reverse for Fidelis Insurance (FIHL)
PYXS

Zacks

2 years ago

After Plunging -12.8% in 4 Weeks, Here's Why the Trend Might Reverse for Fidelis Insurance (FIHL)

Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
PYXS

GlobeNewswire

2 years ago

Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer

Independent Chairman of Sight Sciences Picks Up 14% More Stock
PYXS

Simply Wall St.

2 years ago

Independent Chairman of Sight Sciences Picks Up 14% More Stock

908 Devices Announces MX908 Integration Capabilities
PYXS

Business Wire

2 years ago

908 Devices Announces MX908 Integration Capabilities

Savers Value Village Third Quarter 2023 Earnings: US$0.097 loss per share (vs US$0.078 profit in 3Q 2022)
PYXS

Simply Wall St.

2 years ago

Savers Value Village Third Quarter 2023 Earnings: US$0.097 loss per share (vs US$0.078 profit in 3Q 2022)

Senseonics Holdings, Inc. (AMEX:SENS) Q3 2023 Earnings Call Transcript
PYXS

Insider Monkey

2 years ago

Senseonics Holdings, Inc. (AMEX:SENS) Q3 2023 Earnings Call Transcript

METALLA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2023 AND PROVIDES ASSET UPDATES
PYXS

CNW Group

2 years ago

METALLA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2023 AND PROVIDES ASSET UPDATES

PYXS

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Senseonics Holdings Inc Earnings Call

PYXS

Associated Press Finance

2 years ago

Senseonics: Q3 Earnings Snapshot

Blade Air Mobility, Inc. (NASDAQ:BLDE) Q3 2023 Earnings Call Transcript
PYXS

Insider Monkey

2 years ago

Blade Air Mobility, Inc. (NASDAQ:BLDE) Q3 2023 Earnings Call Transcript

Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results
PYXS

Business Wire

2 years ago

Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results

908 Devices Inc. (NASDAQ:MASS) Q3 2023 Earnings Call Transcript
PYXS

Insider Monkey

2 years ago

908 Devices Inc. (NASDAQ:MASS) Q3 2023 Earnings Call Transcript

Share on Social Networks: